Prostate Specific Membrane Antigen (PSMA) is a surface II membrane glycoprotein in secretory cells of the prostatic epithelium, with expression ?restricted to normal prostate tissue, primary, metastatic prostate cancer and the neovasculature of various nonprostatic epithelial malignancies. PSMA is vastly expressed by prostate cancers, and the expression enhances with androgen-independence, tumor aggressiveness, disease recurrence and metastatic disease. Over expression of PSMA is correlated with high tumor grade, non-diploid tumors, and advanced tumor stage. PSMA is excellent in differentiating between prostatic adenocarcinoma and urothelial carcinoma. PSMA expression is highly restricted to the prostate. It is a useful marker for prostate tumors. It can be used as an effective predictor for tumor progression in prostate cancer
Intended Use: IVD
Antibody Type: Monoclonal
Clone: EP192
Source: Rabbit
Tissue Type/Cancer Type: Prostate